11
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Enhanced Nitric Oxide Synthesis Reverses Salt-Induced Alterations in Blood Flow and Cgmp Levels

, , , , , , & show all
Pages 333-352 | Published online: 03 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

M. A. Bayorh, Mohamed A. Bayorh, R. R. Socci, D. Eatman, M. Wang & M. Thierry-Palmer. (2001) THE ROLE OF GENDER IN SALT-INDUCED HYPERTENSION. Clinical and Experimental Hypertension 23:3, pages 241-255.
Read now

Articles from other publishers (4)

Courtney M. Shea, Gavrielle M. Price, Guang Liu, Renee Sarno, Emmanuel S. Buys, Mark G. Currie & Jaime L. Masferrer. (2020) Soluble guanylate cyclase stimulator praliciguat attenuates inflammation, fibrosis, and end-organ damage in the Dahl model of cardiorenal failure. American Journal of Physiology-Renal Physiology 318:1, pages F148-F159.
Crossref
Undurti N. DasUndurti N. Das. 2011. Molecular Basis of Health and Disease. Molecular Basis of Health and Disease 239 275 .
Undurti N. Das. 2010. Metabolic Syndrome Pathophysiology. Metabolic Syndrome Pathophysiology 86 104 .
U N Das. (2004) Long-chain polyunsaturated fatty acids interact with nitric oxide, superoxide anion, and transforming growth factor-β to prevent human essential hypertension. European Journal of Clinical Nutrition 58:2, pages 195-203.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.